2m 2m 2m 2m 2m 2m 2m
PELTHOS THERAP (PTHS)
NYSE
$21.79-$0.11 (-0.53%)
Price as of Sep 11, 2026 7:30 PM EDT- $83.8MMarket Cap
- -32.59%1-Year Change
- BiotechnologyIndustry
PELTHOS THERAP (PTHS)
$21.79-$0.11 (-0.53%)
PTHS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.90 | ||
Change | -$0.53 (-2.36%) | ||
Open | $22.62 | ||
High | $23.12 | ||
Low | $21.21 | ||
Previous Close | $22.43 | ||
Volume | 18,947 | ||
30-Day Average Volume | 43,446 | ||
1-Week Change | -10.06% | ||
1-Month Change | -23.51% | ||
1-Year Change | -32.59% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.8M | ||
Total Assets | $137.4M | ||
Market Cap | $83.8M | ||
Enterprise Value | $142.3M | ||
Period: QTR TTM FY | |||
Revenue | $15.4M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$7.7M | ||
EBIT | -$23.0M | ||
EBITDA | -$22.0M | ||
Net Working Capital | $31.4M | ||
EPS | -$6.62 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 9 | ||
P/B | -56 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue